Related Experiment Video
Updated: Jul 31, 2026
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
Erectile dysfunction and lower androgenicity in type 1 diabetic patients
O Alexopoulou1, J Jamart, D Maiter
1Service d'Endocrinologie et Nutrition, Cliniques Universitaires St Luc, Université Catholique de Louvain, B-1200 Bruxelles, Belgique.
Diabetes & Metabolism
|June 30, 2001
Summary
Erectile dysfunction (ED) is common in type 1 diabetes, affecting nearly half of patients. It is linked to aging, longer diabetes duration, complications, and lower androgen levels.
Area of Science:
- Endocrinology
- Diabetology
- Men's Health
Background:
- Erectile dysfunction (ED) is a common complication in men with diabetes mellitus.
- Type 1 diabetes (T1D) presents unique challenges in managing chronic conditions and their associated comorbidities.
Purpose of the Study:
- To investigate the clinical characteristics and hormonal profiles of type 1 diabetic patients with and without erectile dysfunction.
- To identify factors associated with erectile dysfunction in this population.
Main Methods:
- A cohort of 51 type 1 diabetic patients was assessed for erectile dysfunction via direct interview.
- Detailed clinical data including chronic complications, lifestyle factors, medications, and a comprehensive hormonal profile (including androgens, gonadotropins, and thyroid hormones) were collected.
Main Results:
- Nearly half (47%) of T1D patients experienced ED, correlating with older age, longer diabetes duration, higher systolic blood pressure, and increased diabetes complications.
- Patients with ED exhibited lower levels of androstenedione (Delta(4)), dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S), and free testosterone (FT).
- Logistic regression identified lower Delta(4), DHEA-S, and higher sex hormone-binding globulin (SHBG) and insulin dose as independent predictors of ED.
Conclusions:
- Erectile dysfunction is highly prevalent in type 1 diabetes.
- ED is significantly associated with clinical factors such as age, diabetes duration, and chronic complications.
- Reduced androgen levels and altered SHBG are implicated in the pathophysiology of ED in type 1 diabetes.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.